A Colombian study of 478 patients found that routine cerebrospinal fluid white cell counts and protein levels could predict ...

Age reversal has moved from laboratory theory into a real human experiment. ER-100 could help reveal how much of aging biology is actually reversible.

Researchers from the University Hospital of Bonn and the University of Bonn have succeeded in dramatically rejuvenating human ...

Sharpen pricing, prioritize molecular diagnostics and genomics, and guide R&D and investment amid point-of-care and self-testing disruption.Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE) -- "Clinical Medical ...

A cell sitting in fluid looks like one of the most passive things in biology. Nutrients drift toward it on the aimless ...

First CNSide payer agreement to include CNSide’s new CSF Molecular Profile tests alongside tumor cell enumerationExpands CNSide contracted payer ...

New Delhi, Oct 6 (PTI) An artificial intelligence-based tool flagged 18,377 people for further tuberculosis testing after analysing chest X-rays of 1,68,568 residents in the national capital's urban ...

CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Cerenome), announced the commercial launch of two new cerebrospinal fluid (CSF)-based molecular profiling tests, available to ...

Roche supplied two molecular testing systems and in the DRC to support PCR test validation for Bundibugyo virus amid Ebola outbreak.

Roche Diagnostics has provided two molecular testing instruments to the Institut National de Santé Publique (INSP), which is supporting the DRC's Ministry of Health-led Ebola response. Roche will ...

Cerenome's CNSide Diagnostics launched two CSF-based molecular profiling tests for CNS cancers, analyzing DNA and RNA.

As the outbreak of Ebola disease caused by Bundibugyo virus continues in the Democratic Republic of Congo (DRC), demand for testing is exceeding current available laboratory capacity, and strategic ...